CDT earnings: real EPS beat/miss history, P/E -0.10. Updated 2026-07-23.
CDT Equity (CDT) Research Hub
CDT Equity (CDT) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 0.25 USD (-58.34%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.10, market cap 0.00B. This hub links to the full technical, earnings and options research available for CDT.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 0.25 USD (-58.34%) |
| 52-week range | 0.2301 USD – 19.1 USD |
| Trend regime | Range |
| 14-day RSI | 10.1 (Oversold) |
| Trailing P/E | -0.10 |
| Market cap | 0.00B |
| Dividend yield | 0.00% |
Available research for CDT
Covered Call on CDT: how it works, illustrative setup around the real 0.25 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on CDT: how it works, illustrative setup around the real 0.25 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on CDT: how it works, illustrative setup around the real 0.25 USD price, max profit/loss, breakeven and when to use it. Educational.
CDT technical analysis: range, last 0.25 USD, RSI 10.1, 52w range 0.2301 USD–19.1 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is CDT in?
CDT Equity (CDT) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is CDT in an uptrend or downtrend?
As of 2026-09-11, CDT is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is CDT's trailing P/E ratio?
CDT's trailing P/E is -0.10, with a market cap of 0.00B. See the earnings research page for full valuation detail.